Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $32.5100 (2.98%) ($31.5300 - $32.7800) on Tue. Feb. 17, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.66% (three month average) | RSI | 44 | Latest Price | $32.5100(2.98%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | SGEN declines -0.3% a day on average for past five trading days. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) IBB(47%) XBI(43%) XLV(37%) QQQ(30%) SPY(30%) | Factors Impacting SGEN price | SGEN will decline at least -1.33% in a week (0% probabilities). VIXM(-18%) TLT(-8%) SHY(-4%) UUP(-3%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.33% (StdDev 2.66%) | Hourly BBV | 0 () | Intraday Trend | 2.8% | | | |
|
5 Day Moving Average | $31.76(2.36%) | 10 Day Moving Average | $31.95(1.75%) | 20 Day Moving Average | $31.95(1.75%) | To recent high | -14% | To recent low | 6.5% | Market Cap | $5.652b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |